SKI Market

A+| A| A-|

Indian Indices

Sensex

75,415.35 231.99
( 0.31%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

63,328.42 1,644.28
(2.67%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sirca Paints India Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

543686

INE792Z01011

83.6783536

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SIRCA

36.72

2387.57

EPS(TTM)

Face Value()

Div & Yield %

11.45

0.48

Back

Natco Pharma receives CDSCO approval for launch of Semaglutide in India

Feb 14,2026

Natco Pharma received approval for Semaglutide from Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide Injection in India. NATCO will launch the product in the India market in March'26.

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

75,415.35 231.99 ( 0.31%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

63,328.42 1,644.28 (2.67%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)